Newsletters

Omada hits 275K cumulative users. More on Pear, Limbix, ATX.

9.19.19

5 min. Read

Excerpts from the Pear Therapeutics Report.

9.13.19

2 min. Read

Livongo’s beyond diabetes revenue. Fitbit loses exec to CVS-Aetna

9.06.19

3 min. Read

Quick data scan on federal contracts. Rethinking platform strategies.

8.30.19

5 min. Read

Novartis predicts Amazon DTx delivery. VR pain relief.

8.22.19

5 min. Read

Excerpts from the 4,400-word AliveCor Report.

8.15.19

3 min. Read

Samsung’s quiet CardioBand FDA clearance. HealthXL’s evidence report.

8.08.19

4 min. Read

CPT vs drug reimbursement pathways. Cancer DTx enforcement discretion.

8.01.19

5 min. Read

The case against Proteus-Otsuka’s digital med. AliveCor’s 6th CEO

7.25.19

4 min. Read

FDA Pre-Cert tested with Pear insomnia DTx.

7.18.19

7 min. Read